home / stock / vrtx / vrtx articles

VRTX Articles, Vertex Pharmaceuticals Incorporated

Stock Information
Company Name: Vertex Pharmaceuticals Incorporated
Stock Symbol: VRTX
Market: NASDAQ
Website: vrtx.com
Menu
VRTX VRTX Quote VRTX Short VRTX News VRTX Articles VRTX Message Board
Get VRTX Alerts

News, Short Squeeze, Breakout and More Instantly...
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrade...
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years | Benzinga

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 12.7% on an annualized basis producing an average annual...

Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades' | Benzinga

On CNBC's “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management named NVIDIA Corporation (NASDAQ:NVDA) a...

Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Arcturus' Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst | Benzinga

Friday, Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) presented Phase 1 results in healthy volunteers and Phase 1b interim data in people with c...

$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today | Benzinga

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 5 years by 9.91% on an annualized basis producing an average annual ...

Arcturus Therapeutics' Early Cystic Fibrosis Trial Results Encouraging - Analyst Cautiously Optimistic | Benzinga

On Tuesday, Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) announced that it will present Phase 1 results in healthy volunteers and new Pha...
SLB, First Solar And 2 Other Stocks Insiders Are Selling | Benzinga

The Nasdaq 100 closed slightly lower on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it coul...

Walmart, Vertex Pharmaceuticals And More On CNBC's 'Final Trades' | Benzinga

Joseph M. Terranova of Virtus Investment Partners named VanEck Semiconductor ETF (NASDAQ:SMH) on CNBC's “Halftime Report Final Trades.&#...

Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades' | Benzinga

On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management said under $30, Pfizer Inc. (NYSE:PFE) is a g...
Next 10